Genetic epidemiology of alpha-1 antitrypsin deficiency in North America and Australia/New Zealand: Australia, Canada, New Zealand and the United States of America

Clinical Genetics

Volumn 64, Issue 5, 2003, Pages 382-397

  de Serres, Frederick J ^a   Blanco, I ^b   Fernandez Bustillo E ^c  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b HOSPITAL VALLE DEL NALÓN   (Spain)

^c HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

Author keywords

Alpha 1 antitrypsin deficiency; Alpha 1 protease; Alpha 1 protease inhibitor; Australia; Canada; Genetic epidemiology; New Zealand; Pi phenotypes; Pi subtypes; Population genetics; United States of America

Indexed keywords

ALPHA 1 ANTITRYPSIN;

ALLELE; ALPHA 1 ANTITRYPSIN DEFICIENCY; AUSTRALIA; CANADA; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; DATA BASE; DISEASE CARRIER; GENE FREQUENCY; GENETIC EPIDEMIOLOGY; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; GEOGRAPHIC DISTRIBUTION; HEREDITY; HUMAN; INFORMATION PROCESSING; JAUNDICE; LIVER DISEASE; LUNG EMPHYSEMA; MAJOR CLINICAL STUDY; MEDICAL LITERATURE; NEW ZEALAND; NORTH AMERICA; PEER REVIEW; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; RACE DIFFERENCE; REVIEW; RISK ASSESSMENT; STATISTICAL ANALYSIS; UNITED STATES;

ALPHA 1-ANTITRYPSIN DEFICIENCY; AUSTRALIA; CANADA; CASE-CONTROL STUDIES; COHORT STUDIES; DATA INTERPRETATION, STATISTICAL; ETHNIC GROUPS; GENE FREQUENCY; HETEROZYGOTE; HUMANS; NEW ZEALAND; PHENOTYPE; UNITED STATES;

EID: 0242525259     PISSN: 00099163     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0004.2003.00143.x     Document Type: Review

References (100)

1. de Serres FJ. Worldwide racial and ethnic distribution of alpha-1-antitrypsin deficiency: details of an analysis of published genetic epidemiol surveys. Chest 2002: 122: 1818-4829.
2. Brantly MT, Nukiwa RG. Crystal, molecular basis of alpha-1-antitrypsin deficiency. Am J Med 1988: 84: 13-31.
3. Pierce JA. Antitrypsin and emphysema. Perspective and prospects. JAMA 1988: 259: 2890-2895.
4. Byth BC, Billingsley GD, Cox DW. Physical and genetic mapping of the serpin gene cluster at 14q32.1: allelic association and a unique haplotype associated with alpha 1-antitrypsin deficiency. Am J Hum Genet 1994: 55: 126-133.
5. Blank CA, Brantly M. Clinical features and molecular characteristics of alpha 1-antitrypsin deficiency. Ann Allergy 1994: 72: 105-120; quiz 120-122.
6. WHO. AAT Deficiency. Geneva: World Health Organization, 1996.
7. Long GL, Chandra T, Woo SL et al. Complete sequence of the cDNA for human alpha 1-antitrypsin and the gene for the S variant. Biochemistry 1984: 23: 4828-4837.
8. Nukiwa T, Satoh K, Brantly ML et al. Identification of a second mutation in the protein-coding sequence of the Z type alpha 1-antitrypsin gene. J Biol Chem 1986: 261: 15989-15994.
9. Carrell RW, Jeppsson JO, Laurell CB et al. Structure and variation of human alpha 1-antitrypsin. Nature 1982: 298: 329-334.
10. Carrell RW, Lomas DA. Alpha 1-antitrypsin deficiency - a model for conformational diseases. N Engl J Med 2002: 346: 45-53.
11. Stoller JK, Snider GL, Brantly ML et al. Standards for the diagnosis and management of individuals with alpha1-antitrypsin deficiency. A report of the Alpha1-Antritrypsin Deficiency Task Force. Am J Resp Clin Care Med 2003 (in press).
12. de Serres F, Blanco I, Bustillo EF. Genetic epidemiology Alpha-1 antitrypsin deficiency: France, Italy, Portugal, Spain. Clin Genet 2003: 63: 490-509.
13. Hutchison DC. Alpha1-antitrypsin deficiency in Europe. geographical distribution of Pi types S and Z. Respir Med 1998: 92: 367-377.
14. Blanco I, Fernandez E, Rodriguez MD et al. Allelic frequencies of alpha-1-antitrypsin gene in randomly selected general population from an area of Asturias (Cantabrian coast, north of Spain). Med Clinica 1999: 113: 366-370.
15. Blanco I, Fernandez E. Alpha1-antitrypsin Pi phenotypes S and Z in Spain: an analysis of the published surveys. Respir Med 2001: 95: 109-114.
16. Blanco I, Fernandez E, Bustillo E. Alpha-1-antitrypsin PI phenotypes S and Z in Europe: an analysis of the published surveys. Clin Genet 2001: 60: 31-41.
17. Blanco I, Bustillo EF, Rodriguez MC. Distribution of alpha1-antitrypsin PI S and PI Z frequencies in countries outside Europe: a meta-analysis. Clin Genet 2001: 60: 431-441.
18. Miravitlles M. Alpha(1)-antitrypsin deficiency: epidemiology and prevalence. Respir Med 2000: 94 (Suppl. C): S12-S15.
19. Blanco I, Fernandez E, Rodriguez MC et al. Frecuencias alelicas del gen de la alfa-1-antitripsina en la poblacion general de una comarca de Asturias [Allelic frequency of the gene of alpha-1-antitrypsin in the general population in a county in Asturias]. Med Clin (Barc) 1999: 113: 366-370.
20. Fagerhol MK, Braend M. Serum prealbumin: polymorphism in man. Science 1965: 149: 986-987.
21. Brantly M. Alpha 1-antitrypsin genotypes and phenotypes. In: Crystal RG, ed. Alpha 1-Antitrypsin Deficiency: Biology Pathogenesis Clinical Manifestations Therapy. New York: Marcel Dekker, Inc., 1996: 45-59.
22. Tazelaar JP, Friedman KJ, Kline RS et al. Detection of alpha 1-antitrypsin Z and S mutations by polymerase chain reaction-mediated site-directed mutagenesis. Clin Chem 1992: 38: 1486-1488.
23. Fagerhol MK, Cox DW. The Pi polymorphism: genetic, biochemical, and clinical aspects of human alpha 1-antitrypsin. Adv Hum Genet 1981: 11: 1-62, 371-372.
24. Ananthakrishnan R, Biegler B, Dennis PM, Alpha 1-antitrypsin phenotypes in paraproteinaemias [letter]. Lancet 1979: 1: 561-562.
25. Clark P. Alpha-1-protease inhibitor phenotypes in Australia. Hum Hered 1982: 32: 225-227.
26. Huggard PR, West MJ, Summers KM. Alpha 1-antitrypsin deficiency alleles and blood pressure in an Australian population. Clin Exp, Pharmacol Physiol 1996: 23: 600-601.
27. Mulley JC. Distribution of the six alpha 1-antitrypsin (PI) subtypes from a sample of blood donors. Aust J Exp Biol Med Sci 1980: 58: 409-414.
28. Mulley JC. Distribution of alpha 1-antitrypsin (PI) subtypes from newborns. Aust J Exp Biol Med Sci 1982: 60: 207-209.
29. Muir A, Whitfield JB. Alpha-1-antitrypsin (protease inhibitor) phenotypes and longevity. Hum Hered 1990: 40: 22-28.
30. Oakeshott JG, Muir A, Clark P et al. Effects of the protease inhibitor (Pi) polymorphism on alpha-1-antitrypsin concentration and elastase inhibitory capacity in human serum. Ann Human Biol 1985: 12: 149-160.
31. McPhee H, Ananthakrishnan R, Taft LI. Antiproteases and Down's syndrome in an Australian population. J Med Genet 1980: 17: 170-173.
32. Ashley MJ, Corey P, Chan-Yeung M. Smoking, dust exposure, and serum alpha 1-antitrypsin. Am Rev Respir Dis 1980: 121: 783-788.
33. Chan-Yeung M, Ashley MJ, Corey P et al. Pi phenotypes and the prevalence of chest symptoms and lung function abnormalities in workers employed in dusty industries. Am Rev Respir Dis 1978: 117: 239-245.
34. Horne SL, Clarke ME, Barnett GD. Alpha-1-antrypsin deficiency: Its effect on pulmonary function in Saskatchewan grain buyers. Occupational Pulmonry Disease: Focus on Grain Dust and Health. New York: Academic Press, 1980: 347-356.
35. Moroz SP, Cutz E, Cox DW et al. Liver disease associated with alpha1-antitrypsin deficiency in childhood. J Pediatr 1976: 88: 19-25.
36. Talamo RC, Thurlbeck WM. Alpha-antitrypsin Pi types in postmortem blood. Am Rev Respir Dis 1975: 112: 201-207.
37. Singh R, Horne SL, Gerrard JW et al. Alpha 1-antitrypsin phenotypes in Canadian Metis. Hum Hered 1983: 33: 181-183.
38. Cox DW, Simpson NE, Jantti R. Group-specific component, alpha1-antitrypsin and esterase D in Canadian Eskimos. Hum Hered 1978: 28: 341-350.
39. Joly J, Richer G, Boisvert F et al. alpha-1-Antitrypsin phenotypes in French Canadian newborns. Hum Hered 1980: 30: 1-2.
40. Ashley MJ, Chan-Yeung M, Corey PN. Pi phenotypes in North American workers: racial differences and comparisons with reported frequencies. Hum Hered 1980: 30: 107-111.
41. Janus ED, Joyce PR, Sheat JM et al. Alpha-1-antitrypsin variants in New Zealand. N Z Med J 1975: 82: 289-291.
42. Kueppers F. Serum alpha-1-antitrypsin levels. N Engl J Med 1968: 279: 164-165.
43. Kueppers F. Alpha1-antitrypsin deficiency. Birth Defects Orig Artie Ser 1976: 12: 213-222.
44. Kueppers F, Utz G, Simon B. Alpha1-antitrypsin deficiency with M-like phenotype. J Med Genet 1977: 14: 183-186.
45. Kueppers F, Offord KP. Alpha-1 antitrypsin elevation in healthy neonates. J Lab Clin Med 1979: 94: 475-480.
46. Roberts A, Kagan A, Rhoads GG et al. Antitrypsin and chronic obstructive pulmonary disease among Japanese-American men. Chest 1977: 72: 489-491.
47. Lee CC, Kueppers F, Harpel B et al. Alpha-1-antitrypsin (Pi) types in Korean and Chinese populations. Hum Genet 1981: 57: 327-328.
48. Evans HE, Bognacki NS, Perrott LM et al. Prevalence of of alpha 1-antitrypsin Pi types among newborn infants of different ethnic backgrounds. J Pediatr 1977: 90: 621-624.
49. DeCroo S, Kamboh MI, Ferrell RE. Population genetics of alpha-1-antitrypsin polymorphism in US whites, US blacks and African blacks. Hum Hered 1991: 41: 215-221.
50. Pierce JA, Eradio B, Dew TA. Antitrypsin phenotypes in St. Louis. JAMA 1975: 231: 609-612.
51. Lieberman J, Gaidulis L, Roberts L. Racial distribution of alpha1-antitrypsin variants among junior high school students. Am Rev Respir Dis 1976: 114: 1194-1198.
52. Cohen BH, Ball WC, Bias WB Jr, et al. A genetic-epidemiologic study of chronic obstructive pulmonary disease. I. Study design and preliminary observations. Johns Hopkins Med J 1975: 137: 95-104.
53. Schwartz RH, Van Ess JD, Johnstone DE et al. Alpha-1 antitrypsin in childhood asthma. J Allergy Clin Immunol 1977: 59: 31-34.
54. Rynbrandt DJ, Ihrig J, Kleinerman J. Serum trypsin inhibitory capacity and Pi phenotypes. I. Methods and control values. Am J Clin Pathol 1975: 63: 251-260.
55. Gerblich AA, Kleinerman J, Rynbrandt DJ et al. Pi-Z phenotypes in a pulmonary clinic. Their prevalence and physiologic state. Am J Clin Pathol 1978: 69: 509-513.
56. Dykes DD, Miller SA, Polesky HF. Distribution of alpha 1-antitrypsin variants in a US white population. Hum Hered 1984: 34: 308-310.
57. Morse JO, Lebowitz MD, Knudson RJ et al. Relation of protease inhibitor phenotypes to obstructive lung diseases in a community. N Engl J Med 1977: 296: 1190-1194.
58. Webb DR, Hyde RW, Schwartz RH et al. Serum alpha 1-antitrypsin variants. Prevalence and clinical spirometry. Am Rev Respir Dis 1973: 108: 918-925.
59. Rossner B. Fundamentals of Biostatistics. Duxbury Press, 1986.
60. Kong A, Barnett GO, Mosteller F et al. How medical professionals evaluate expressions of probablility. N Eng J Med 1986: 315: 740-744.
61. Armitage P, Berry G, Matthews JNS. Statistical Method in Medical Research. Blackwell Publishing, 2001.
62. Brantly ML, Paul LD, Miller BH et al. Clinical features and history of the destructive lung disease associated with alpha-1-antitrypsin deficiency of adults with pulmonary symptoms. Am Rev Respir Dis 1988: 138: 327-336.
63. Lee JH, Brantly M. Molecular mechanisms of alpha1-antitrypsin null alleles. Respir Med 2000: 94 (Suppl. C): S7-S11.
64. Crystal RG, Brantly ML, Hubbard RC et al. The alpha 1-antitrypsin gene and its mutations. Clinical consequences and strategies for therapy. Chest 1989: 95: 196-208.
65. Laurell C, Eriksson S. The electrophoretic alpha-1-globin pattern of serum alpha-1-antitrypsin deficiency. Scand J Clin Invest 1963: 15: 132-140.
66. Mahadeva R, Lomas DA. Genetics and respiratory disease. 2. Alpha 1-antitrypsin deficiency, cirrhosis and emphysema. Thorax 1998: 53: 501-505.
67. Eden E, Mitchell D, Mehlman B et al. Atopy, asthma, and emphysema in patients with severe alpha-1-antitrypysin deficiency. Am J Respir Crit Care Med 1997: 156: 68-74.
68. King MA, Stone JA, Diaz PT et al. Alpha 1-antitrypsin deficiency: evaluation of bronchiectasis with CT. Radiology 1996: 199: 137-141.
69. Griffith ME, Lovegrove JU, Gaskin G et al. C-antineutrophil cytoplasmic antibody positivity in vasculitis patients is associated with the Z allele of alpha-1-antitrypsin, and P-antineutrophil cytoplasmic antibody positivity with the S allele. Nephrol Dial Transplant 1996: 11: 438-443.
70. Phelps RG, Shoji T. Update on panniculitis. Mt Sinai J Med 2001: 68: 262-267.
71. Pianka JD, Ricci P. Cirrhosis associated with heterozygous alpha-1-antitrypsin deficiency preceded by a remote history of panniculitis. Am J Gastroenterol 2000: 95: 1848.
72. Michalski JP, McCombs CC, Scopelitis E et al. Alpha 1-antitrypsin phenotypes, including M subtypes, in pulmonary disease associated with rheumatoid arthritis and systemic sclerosis. Arthritis Rheum 1986: 29: 586-591.
73. Schievink WI, Katzmann JA, Piepgras DG. Alpha-1-antitrypsin deficiency in spontaneous intracranial arterial dissections. Cerebrovasc Dis 1998: 8: 42-44.
74. Lolin YI, Ward AM. Alpha-1-antitrypsin phenotypes and associated disease patterns in neurological patients. Acta Neurol Scand 1995: 91: 394-398.
75. Talmud PJ, Martin S, Steiner G et al. Progression of atherosclerosis is associated with variation in the alpha (1) -antitrypsin gene. Arteriosclerosis Thrombosis Vascular Biol 2003: 23: 644-649.
76. Feld RD. Heterozygosity of alpha 1-antitrypsin: a health risk? Crit Rev Clin Laboratory Sci 1989: 27: 461-481.
77. Gourley MF, Gourley GR, Gilbert EF et al. Alpha 1-antitrypsin deficiency and the PiMS phenotype: case report and literature review. J Pediatr Gastroenterol Nutr 1989: 8: 116-121.
78. Turino GM, Barker AF, Brantly ML et al. Clinical features of individuals with PI*SZ phenotype of alpha 1-antitrypsin deficiency: Alpha 1-Antitrypsin Deficiency Registry Study Group. Am J Respir Crit Care Med 1996: 154: 1718-1725.
79. Lieberman J. Heterozygous and homozygous alpha-antitrypsin deficiency in patients with pulmonary emphysema. N Engl J Med 1969: 281: 279-284.
80. Kueppers F, Fallat R, Larson RK. Obstructive lung disease and alpha-1-antitrypsin deficiency gene heterozygosity. Science 1969: 165: 899-901.
81. Mittman C. The PiMZ phenotype: is it a significant risk factor for the development of chronic obstructive lung disease? Am Rev Respir Dis 1978: 118: 649-652.
82. Lieberman J, Silton RM, Agliozzo CM et al. Hepatocellular carcinoma and intermediate alpha 1-antitrypsin deficiency (MZ phenotype). Am J Clin Pathol 1975: 64: 304-310.
83. Cruz M, Molina JA, Pedrola D et al. Cirrhosis and heterozygous alpha1-antitrypsin deficiency in a 4-year-old girl. Helv Paediatr Acta 1976: 30: 501-507.
84. Carlson J, S. Eriksson, Chronic 'cryptogenic' liver disease and malignant hepatoma in intermediate alpha 1-antitrypsin deficiency identified by a Pi Z-specific monoclonal antibody. Scand J Gastroenterol 1985: 20: 835-842.
85. Pittschieler K. Liver disease and heterozygous alpha-1-antitrypsin deficiency. Acta Paediatr Scand 1991: 80: 323-327.
86. Pittschieler K. Heterozygotes and liver involvement. Acta Paediatr (Suppl. 393) 1994: 21-23.
87. Lieberman J, Winter B, Sastre A. Alpha 1-antitrypsin Pi-types in 965 COPD patients. Chest 1986: 89: 370-373.
88. Lima LC, Matte U, Leistner S et al. Molecular analysis of the Pi*Z allele in patients with liver disease. Am J Med Genet 2001: 104: 287-290.
89. Graziadei IW, Joseph JJ, Wiesner RH et al. Increased risk of chronic liver failure in adults with heterozygous alpha 1-antitrypsin deficiency. Hepatology 1998: 28: 1058-1063.
90. Colp C, Pappas J, Moran D, Lieberman J. Variants of alpha-1-antitrypsin in Puerto Rican children with asthma. Chest 1993: 103: 812-815.
91. Dahl M, Tybjaerg-Hansen A, Lange P et al. Change in lung function and morbidity from chronic obstructive pulmonary disease in alpha1-antitrypsin MZ heterozygotes: a longitudinal study of the general population. Ann Intern Med 2002: 136: 270-279.
92. Yoon D, Kueppers F, Genta RM et al. Role of alpha-1-antichymotrypsin deficiency in promoting cirrhosis in two siblings with heterozygous alpha-1-antitrypsin deficiency phenotype SZ. Gut 2002: 50: 730-732.
93. Mayer AS, Stoller JK, Bucher Bartelson B et al. Occupational exposure risks in individuals with PI*Z alpha (1) - antitrypsin deficiency. Am J Respir Crit Care Med 2000: 162: 553-558.
94. Inselman LS, Bognacki NS, Evans HE. Alpha1-antitrypsin phenotypes in asthmatic children of Hispanic background [letter]. Chest 1978: 74: 600.
95. Shohat T, Shaw SJ, Sparkes RS et al. Polymorphic gene markers in Mexican-Americans residing in southern California. Hum Hered 1995: 45: 150-156.
96. Schwartz RH, Van Ess JD, Roghmann K et al. Screening for alpha-1-antitrypsin deficiency. Pediatr Resp 1975: 9: 299.
97. Shigeoka JW, Hall WJ, Hyde RW et al. The prevalence of alpha-antitrypsin heterozygotes (Pi MZ) in patients with obstructive pulmonary disease. Am Rev Respir Dis 1976: 114: 1077-1084.
98. Bufton L, Magenis RE, Lovrien RE. Alpha-1-antitrypsin protease inhibitor (Pi) phenotypes in Down's syndrome patients and their parents. Clin Genet 1982: 21: 14-18.
99. Kueppers F, Christopherson MJ. Alpha1-antitrypsin: further genetic heterogeneity revealed by isoelectric focusing. Am J Hum Genet 1978: 30: 359-365.
100. Kueppers F, Black LF. Alpha1-antitrypsin and its deficiency. Am Rev Respir Dis 1974: 110: 176-194.